Venus Medtech (Hangzhou) Balance Sheet Health
Financial Health criteria checks 4/6
Venus Medtech (Hangzhou) has a total shareholder equity of CN¥3.3B and total debt of CN¥778.7M, which brings its debt-to-equity ratio to 23.4%. Its total assets and total liabilities are CN¥5.0B and CN¥1.7B respectively.
Key information
23.4%
Debt to equity ratio
CN¥778.68m
Debt
| Interest coverage ratio | n/a |
| Cash | CN¥1.45b |
| Equity | CN¥3.32b |
| Total liabilities | CN¥1.68b |
| Total assets | CN¥5.00b |
Recent financial health updates
No updates
Recent updates
Financial Position Analysis
Short Term Liabilities: 2500's short term assets (CN¥2.1B) exceed its short term liabilities (CN¥633.3M).
Long Term Liabilities: 2500's short term assets (CN¥2.1B) exceed its long term liabilities (CN¥1.0B).
Debt to Equity History and Analysis
Debt Level: 2500 has more cash than its total debt.
Reducing Debt: 2500's debt to equity ratio has increased from 20% to 23.4% over the past 5 years.
Balance Sheet
Cash Runway Analysis
For companies that have on average been loss-making in the past, we assess whether they have at least 1 year of cash runway.
Stable Cash Runway: 2500 has sufficient cash runway for more than a year based on its current free cash flow.
Forecast Cash Runway: Insufficient data to determine if 2500 has enough cash runway if its free cash flow continues to grow or shrink based on historical rates.